Hans Ghayee

CLIN PROF

MD-MEDICINE

GRANTS

  • GRANT
    A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants with Classic Congenital Adrenal Hyperplasia
    Crinetics Pharmaceuticals30 Apr 2026 - 29 Apr 2031
    Active
  • GRANT
    SDHB Pheo para-Tumor Vaccine Development for SDHB
    Sdhb Pheo Para Coalition19 Mar 2026 - 30 Apr 2029
    Active
  • GRANT
    A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
    Corcept Therapeutics25 Apr 2025 - 19 Sep 2025
    Expired
  • GRANT
    VA IPA-Yiling Xu
    17 Aug 2023 - 31 Dec 2024
    Expired
  • GRANT
    Preclinical Study of a Combination Therapy for PPGL tumors with HIF2 alpha inhibitor Belzutifan plus Polyamine Analogue Inhibitor DENSPM in a PPGL Xenograft Mouse Model
    Sdhb Pheo Para Coalition27 Apr 2023 - 30 Apr 2027
    Active
  • GRANT
    Locomotor Training with Testosterone to Promote Bone and Muscle Health
    Craig H Neilsen Foundation15 Jun 2021 - 30 Jan 2023
    Expired
  • GRANT
    Preclinical evaluation of the efficacy and mechanism of action for an alkylated polyamine analogue diethylnorspermine in treating pheochromocytoma/paraganglioma
    National Institute of Health Ncats9 Jun 2020 - 31 May 2023
    Expired
  • GRANT
    Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant
    Corcept Therapeutics7 Aug 2019 - 29 Mar 2023
    Closed
  • GRANT
    VA IPA-Yiling Xu
    15 May 2019 - 31 May 2020
    Expired
  • GRANT
    SDHB Coalition
    Sdhb Pheo Para Coalition21 Apr 2019 - 30 Apr 2027
    Active
  • GRANT
    VA IPA- YILING XU
    1 Apr 2017 - 31 Mar 2019
    Expired
  • GRANT
    AN OPEN LABEL STUDY TO ASSESS THE SAFETY AND EFFICACY OFCOR-003 (2S, 4R-KETOCONAZOLE) IN THE TREATMENT OF ENDOGENOUS Cushing's Syndrome
    Strongbridge Biopharma1 Oct 2015 - 6 May 2018
    Expired
  • GRANT
    Institutional Research Grant
    American Cancer Society1 Jan 2012 - 31 Dec 2015
    People funded by this grant:
    • Wang R,
    • Kim J,
    • Willson J,
    • Nam Y,
    • Kendzor D